Pier Capital, LLC Prothena Corp Public LTD CO Transaction History

Pier Capital, LLC

  • $641 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024
BUY
$24.75 - $40.66 $4,727 - $7,766
191 Added 0.34%
57,020 $1.41 Million
Q4 2023

Feb 15, 2024
SELL
$32.31 - $52.32 $20,258 - $32,804
-627 Reduced 1.09%
56,829 $2.07 Million
Q3 2023

Nov 14, 2023
BUY
$47.3 - $70.6 $2.72 Million - $4.06 Million
57,456 New
57,456 $2.77 Million

Others Institutions Holding PRTA

# of Institutions
183
Shares Held
42.8M
Call Options Held
77.7K
Put Options Held
92.7K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $788M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email